Skip to main content
. 2014 Mar 18;7(3):248–250. doi: 10.1093/ckj/sfu026

Table 1.

Comparison of patient characteristics and treatments between those with and without hypoglycemic episodes following insulin treatment for hyperkalemia

Hypoglycemic (n = 29) Nonhypoglycemic (n = 192) P-value
Age (years) 51 ± 14 56 ± 14 0.07
Male (%) 63 62 0.47
African American (%) 62 49 0.19
BMI (kg/m2) 25.9 ± 5.5 28.6 ± 7.4 0.06
History of diabetes (%) 34 54 0.05
Taking diabetes medication prior to admission (%) 14 70 0.02
Pretreatment glucose level mmol/L (mg/dL) 5.8 ± 3.5 (104 ± 63) 9.0 ± 8.2 (162 ± 148) 0.04
Nadir glucose level mmol/L (mg/dL) 2.6 ± 0.5 (46 ± 9) 8.9 ± 5.7 (160 ± 102) 0.01
Received dextrose with insulin (%) 100 93 0.17
Doses (25 g IV or oral) of dextrose given before hypoglycemia 1.2 ± 0.4 1.2 ± 0.5 0.20

Data are presented as mean ± SD unless otherwise noted.